<DOC>
	<DOCNO>NCT01451814</DOCNO>
	<brief_summary>The primary objective study test manualized adaptation positive psychotherapy ( PPT ) smoke cessation ( PPT-S ) . The investigator conduct preliminary randomize clinical trial ( N = 80 ) examine feasibility , acceptability , efficacy PPT-S 26 week follow comparison standard smoke cessation treatment . Both treatment deliver individual 6 session 6 week , include provision transdermal nicotine patch . The effect size estimate Stage 1b research provide foundation future application conduct large-scale , Stage II , randomize clinical trial .</brief_summary>
	<brief_title>Development Positive Psychotherapy Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>smoke least 5 cigarette per day longer one year ongoing tobacco product use willing use transdermal nicotine patch report least 5 0 10 scale rating importance quit smoking . currently experience psychotic symptom , affective disorder ( major depression , dysthymia , mania ) substance use disorder ( nicotine dependence ) take prescribed psychotropic medication receive form psychotherapy concomitantly use pharmacotherapies smoke cessation contraindication use transdermal nicotine patch .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>smoke cessation</keyword>
</DOC>